SMSivaraman Bala Murugan

Sivaraman Bala Murugan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sivaraman Bala Murugan has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Current landscape of drug induced retinal vasculitis

    by Sivaraman Bala Murugan, Aneena Anna Thomas, Rakshita Deepak Kene, Aditya Rajan, Anup Kelgaonkar, Vedhanayagi Rajesh, Anjana Somanath, Padmamalini Mahendradas, Gokulvasanth Deivasenathipathi, Parthopratim Dutta Majumder

    Drug-induced retinal vasculitis (DIRV), a complex diagnostic entity, masquerades as infectious or primary autoimmune diseases. Delineating them is a daunting task. This update aims to consolidate clinical evidence focussing on characteristic “vascular signatures” using advanced multimodal imaging tools. Type III (immune complex-mediated) and Type IV (T-cell-mediated) hypersensitivity pathways were involved in diverse range of drugs causing DRIV. The critical therapeutic strategies are highlighted to prevent permanent ischemic damage. Advances in the recent metagenomic markers are added to aid the clinician from a practical standpoint to aid in preventive and personalised ophthalmic care.

  • Open Access

    Assessing the Combined Diagnostic Value of Serum ACE Levels, Mantoux Test and Lymphopenia in Uveitis Patients from a Tertiary Eye Care Center in Southern India

    by Harsha Puthanveettil, Siva Raman Bala Murugan, Bharat Gurnani, Kirandeep Kaur, Srinivasan Sanjay

    Purpose: To evaluate the diagnostic utility of serum angiotensin-converting enzyme (ACE) levels, along with Mantoux test and lymphocyte count, in patients with uveitis, with particular emphasis on differentiating ocular sarcoidosis and ocular tuberculosis. Methods: This prospective observational study was conducted at a tertiary eye care center in South India from December 2020 to June 2022. A total of 95 patients (118 eyes) with active uveitis were included. All patients underwent detailed clinical evaluation and standardized investigations including serum ACE levels, Mantoux test, and lymphocyte count. Diagnostic performance was assessed using sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Receiver operating characteristic (ROC) curves were used to evaluate discriminative ability. Results: The cohort had a mean age of 44.52± 13.77 years with near-equal gender distribution (50.5% males). Anterior uveitis was most common (38.1%), followed by intermediate (18.6%) and posterior uveitis (16.9%). Defective vision (67.6%) and pain (44.1%) were predominant symptoms. Posterior uveitis was significantly higher in tuberculosis (53.3% vs 10.7%, p=0.002), while intermediate uveitis was more common in sarcoidosis (46.4% vs 6.7%, p=0.008). Elevated ACE (≥ 52 IU/L) was seen in 89.5% of sarcoidosis vs 33.3% tuberculosis (p=0.008; AUROC 0.819). Mantoux positivity was higher in tuberculosis (58.3%; AUROC 0.835). Lymphopenia showed 100% specificity but 10.5% sensitivity. Conclusion: Serum ACE is a useful adjunctive biomarker in the diagnosis of ocular sarcoidosis but lacks specificity when used in isolation. A combined approach incorporating serum ACE, Mantoux test, and lymphocyte count enhances diagnostic precision in uveitis, particularly in distinguishing sarcoidosis from tuberculosis in endemic regions.

  • Bilateral necrotising retinitis caused by cytomegalovirus in an immunocompetent host: A case report

    by Sivaraman Bala Murugan, Yuvraj Madhav, Prithiviraj Nagarajan

    Retinal necrosis (RN) is typically caused by herpesviridae, most commonly varicella-zoster virus (VZV), followed by HSV and occasionally cytomegalovirus (CMV). While RN is generally unilateral, bilateral cases are more common in immunocompromised individuals. We report a rare case of bilateral retinal necrosis caused by CMV in an immunocompetent 31-year old male. He initially presented with defective vision in both eyes and was diagnosed after PCR confirmed the CMV as the causative agent. Despite initial treatment with intravenous acyclovir, he showed persistent vitreous inflammation with membranes, leading to intravitreal ganciclovir injections. While the patient experienced significant improvement, complications such as a macular hole and epiretinal membrane developed. This case highlights the need for clinicians to consider CMV as a possible cause of RN in immunocompetent adults, especially in non-responding cases, and underlines the importance of early etiological diagnosis and targeted treatment.

  • Open Access

    OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial

    by Mai Alhelaly, Ceren Soylu, Deniz Oncel, Giulia Corradetti, Keren Chen, Nicholas J. Jackson, Sivakumar R. Rathinam, John A. Gonzales, Radhika Thundikandy, Anuradha Vadakke Kanakath, et al.


  • Open Access

    Assessment of Subjective Visual Experiences During Intraocular Surgery and Intravitreal Injection Among Uveitis Patients at a Tertiary Eye Hospital: A Cross-Sectional Observational Study

    by Sivaraman Bala Murugan, Bharat Gurnani, Kirandeep Kaur

    Introduction Patients frequently report visual sensations during ophthalmic surgery; however, data in uveitic eyes remain limited. Patients with Uveitis represent a unique population group because of the chronic inflammatory course, systemic associations, and prolonged pharmacologic exposure, which may influence intraoperative perception and anxiety. This study aimed to characterize the nature and impact of intraoperative subjective visual experiences in patients with uveitis undergoing intraocular surgery or intravitreal injection and to evaluate the association of these experiences with uveitic activity, preoperative anxiety, and intraoperative physiological fluctuations. Methods This prospective cross-sectional observational study was conducted at a tertiary eye care hospital between June 2022 and July 2023. Seventy-six patients with uveitis undergoing anterior segment surgery, posterior segment surgery, or intravitreal injection were enrolled. Patients younger than 18 years, those requiring general anaesthesia, or with psychiatric/systemic disorders affecting perception were excluded. Demographic variables, uveitis type, systemic history, and visual acuity were recorded. Preoperative anxiety was assessed using the Amsterdam Preoperative Anxiety and Information Scale (APAIS). Intraoperative visual phenomena were evaluated postoperatively using a standardized questionnaire, while vital parameters (blood pressure, pulse rate, and SpO2) were monitored throughout surgery. Results Among 76 patients (mean age 56 years; 48.7% male, 51.3% female), 60.5% underwent anterior segment surgery, 17.1% posterior segment surgery, and 22.3% intravitreal injections. All retained light perception intraoperatively. Common experiences included seeing colours (76.1% anterior; 61.5% posterior; 41.2% intravitreal), floaters (63%, 23%, 64.7%, respectively), and flashes (43.4%, 61.5%, 23.5%). Frightening perceptions occurred in 26.3% overall, significantly more in male patients (P = 0.008) and those with better preoperative visual acuity (P = 0.014). Notable intraoperative fluctuations were observed in systolic/diastolic blood pressure and pulse rate. Conclusion Patients with uveitis consistently experience intraoperative visual sensations irrespective of disease activity or surgical type. The occurrence of fear underscores the need for structured preoperative counselling, tailored anaesthetic management, and vigilant systemic monitoring to enhance patient comfort and surgical safety. Trial Registration No. CTRI/2022/07/043763.


  • Open Access

    Artificial Intelligence in Uveitis: Innovations in Diagnosis and Therapeutic Strategies

    by Siva Raman Bala Murugan, Srinivasan Sanjay, Anjana Somanath, Padmamalini Mahendradas, Aditya Patil, Kirandeep Kaur, Bharat Gurnani

    In the dynamic field of ophthalmology, artificial intelligence (AI) is emerging as a transformative tool in managing complex conditions like uveitis. Characterized by diverse inflammatory responses, uveitis presents significant diagnostic and therapeutic challenges. This systematic review explores the role of AI in advancing diagnostic precision, optimizing therapeutic approaches, and improving patient outcomes in uveitis care. A comprehensive search of PubMed, Scopus, Google Scholar, Web of Science, and Embase identified over 10,000 articles using primary and secondary keywords related to AI and uveitis. Rigorous screening based on predefined criteria reduced the pool to 52 high-quality studies, categorized into six themes: diagnostic support algorithms, screening algorithms, standardization of Uveitis Nomenclature (SUN), AI applications in management, systemic implications of AI, and limitations with future directions. AI technologies, including machine learning (ML) and deep learning (DL), demonstrated proficiency in anterior chamber inflammation detection, vitreous haze grading, and screening for conditions like ocular toxoplasmosis. Despite these advancements, challenges such as dataset quality, algorithmic transparency, and ethical concerns persist. Future research should focus on developing robust, multimodal AI systems and fostering collaboration among academia and industry to ensure equitable, ethical, and effective AI applications. The integration of AI heralds a new era in uveitis management, emphasizing precision medicine and enhanced care delivery.


  • Open Access

    Bilateral acute vision loss as the initial presentation of chronic myeloid leukemia in a young female

    by Sivaraman Balamurugan, Kirandeep Kaur, Bharat Gurnani, Anushri Agrawal

    Chronic myeloid leukemia (CML) is a hematological malignancy characterized by structural/functional changes and increased neutrophils. Rarely, ophthalmic manifestations are the first clue toward underlying pathology. We report a case of a 34-year-old woman who presented with sudden-onset diminution of vision in both eyes. On examination, she was diagnosed with panuveitis in the right eye and choroiditis in the left eye. Further investigations revealed an underlying CML in the accelerated phase. The patient was managed with systemic immunomodulators along with topical and periocular steroids. Prompt diagnosis and management in collaboration with an oncologist and hematologist helped us achieve a good outcome.


  • Open Access

    First clinical case series of frosted branch angiitis: A diagnostic algorithm is suggested

    by Bharat Gurnani, Sivaraman Balamurugan, Anuradha Kanakath, Kirandeep Kaur, Abhay Gupta, Sameer Chaudhary

    Key Clinical Message: FBA is a clinical diagnosis of a diverse spectrum, which needs a high index of suspicion to identify the possible specific etiologies. The zones of retinal involvement can help in predicting the final visual outcome. The proposed diagnostic algorithm facilitates meticulous evaluation and targeted treatment to improve the final visual outcome. Frosted branch angiitis is a clinical diagnosis of a diverse spectrum, which needs a high index of suspicion to identify the possible specific etiologies. We present a series of three cases of FBA with an attempt to formulate a diagnostic algorithm and refine the definition of FBA.


  • Open Access

    Peripapillary retinal lesions: Is it multiple evanescent white dot syndrome?

    by Sivaraman Balamurugan, Anjana Somanath